Deciduous Therapeutics
San Francisco
About Deciduous Therapeutics
Deciduous Therapeutics is an aging therapeutics company developing a novel class of immune-modulatory therapies that clear senescent cells and promote a healthy lifespan. Deciduous is led by Anil Bhushan, a professor at UCSF, and Robin Mansukhani, a five-time biotech founder.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 11 – 50
- Estimated revenue: $1K – $10K
- Total funding: $16.5M
- Funding stage: Seed
- Last round: Seed (Dec 2022)
- Website: deciduoustx.com
- Phone: 650-206-9082
Industries & Categories
Biopharma, Biotechnology, Health Care
Social Profiles
Canonical: https://fsome.com/organization/deciduous-therapeutics-4849 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.